Press Releases
| [+] |
September 22, 2003 Ambrx Assembles World Class Team and Raises $12.5 Million to Apply Breakthrough SAN DIEGO, CA – September 22, 2003 – Ambrx, Inc., a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics, announced that Richard D. DiMarchi, Ph.D. has been appointed as founding Chief Executive Officer and Thomas O. Daniel, M.D. has joined the company as Chief Scientific Officer.… Read More |
Articles
- April 1, 2005
Unnatural Amino Acid Could Prove Boon for Protein Therapeutics
Science Magazine - March 14, 2005
Giving Biotechnology A Chemical Push
Chemical & Engineering News - March 14, 2005
Watching Peptide Drugs Grow Up
Chemical & Engineering News - January 12, 2004
The Code Breakers
Bio-IT World - October 6, 2003
Executive Profile - RICHARD D. DIMARCHI
SD Business Journal (paid access) - September 29, 2003
Ambrx Inc. Lands $12.5M in First-Round Funding
SD Business Journal (paid access) - September 23, 2003
First-Round Financing of $12.5M Puts Ambrx On Development Path
BioWorld Today - September 22, 2003
Schultz seeks another success with Ambrx
The Daily Deal
